Drug patents expiry will save healthcare billions
European healthcare providers could benefit from savings of over €3.8 billion a year by 2014 as patents expire on leading pharmaceutical products and the market opens up to generics competition, according to latest research from independent market analyst Datamonitor (www.datamonitor.com).

















